Nevro Names Dr. David Caraway CMO

Nevro announced the appointment of David Caraway, MD, PhD, as its CMO.

Advertisement

Nevro is a medical device company focused on developing evidence-based solutions in the neuromodulation space.

 

Dr. Caraway has more than 20 years of experience in the neuromodulation space and has held leadership roles in professional societies such as the North American Neuromodulation Society and American Society of Interventional Pain Physicians.

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.